C Kellendonk
Overview
Explore the profile of C Kellendonk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
2465
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Biezonski D, Shah R, Krivko A, Cha J, Guilfoyle D, Hrabe J, et al.
Transl Psychiatry
. 2016 Sep;
6(9):e884.
PMID: 27598968
Stimulant treatment is highly effective in mitigating symptoms associated with attention-deficit/hyperactivity disorder (ADHD), though the neurobiological underpinnings of this effect have not been established. Studies using anatomical magnetic resonance imaging...
2.
Canetta S, Bolkan S, Padilla-Coreano N, Song L, Sahn R, Harrison N, et al.
Mol Psychiatry
. 2016 Jun;
21(7):857.
PMID: 27321207
No abstract available.
3.
Canetta S, Bolkan S, Padilla-Coreano N, Song L, Sahn R, Harrison N, et al.
Mol Psychiatry
. 2016 Feb;
21(7):956-68.
PMID: 26830140
Abnormalities in prefrontal gamma aminobutyric acid (GABA)ergic transmission, particularly in fast-spiking interneurons that express parvalbumin (PV), are hypothesized to contribute to the pathophysiology of multiple psychiatric disorders, including schizophrenia, bipolar...
4.
Bolkan S, Carvalho Poyraz F, Kellendonk C
Neuroscience
. 2015 Jun;
321:77-98.
PMID: 26037801
Schizophrenia is a heterogeneous and poorly understood mental disorder that is presently defined solely by its behavioral symptoms. Advances in genetic, epidemiological and brain imaging techniques in the past half...
5.
Frederick A, Yano H, Trifilieff P, Vishwasrao H, Biezonski D, Meszaros J, et al.
Mol Psychiatry
. 2015 Jan;
20(11):1373-85.
PMID: 25560761
Hetero-oligomers of G-protein-coupled receptors have become the subject of intense investigation, because their purported potential to manifest signaling and pharmacological properties that differ from the component receptors makes them highly...
6.
Izawa R, Jaber M, Deroche-Gamonet V, Sillaber I, Kellendonk C, Le Moal M, et al.
Neuroscience
. 2005 Dec;
137(3):915-24.
PMID: 16326019
Several findings suggest that glucocorticoid hormones influence the propensity of an individual to develop cocaine abuse. These hormones activate two related transcription factors, the glucocorticoid receptor and the mineralocorticoid receptor....
7.
Kellendonk C, Tronche F, Reichardt H, Bauer A, Greiner E, Schmid W, et al.
Ernst Schering Res Found Workshop
. 2002 Oct;
(40):305-18.
PMID: 12355723
No abstract available.
8.
Otto C, Kovalchuk Y, Wolfer D, Gass P, Martin M, Zuschratter W, et al.
J Neurosci
. 2001 Jul;
21(15):5520-7.
PMID: 11466423
The pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor (PAC1) is a G-protein-coupled receptor binding the strongly conserved neuropeptide PACAP with 1000-fold higher affinity than the related peptide vasoactive...
9.
Gass P, Kretz O, Wolfer D, Berger S, Tronche F, Reichardt H, et al.
EMBO Rep
. 2001 Mar;
1(5):447-51.
PMID: 11258486
To dissect the effects of corticosteroids mediated by the mineralocorticoid (MR) and the glucocorticoid receptor (GR) in the central nervous system, we compared MR-/- mice, whose salt loss syndrome was...
10.
Balsalobre A, Brown S, Marcacci L, Tronche F, Kellendonk C, Reichardt H, et al.
Science
. 2000 Sep;
289(5488):2344-7.
PMID: 11009419
In mammals, circadian oscillators reside not only in the suprachiasmatic nucleus of the brain, which harbors the central pacemaker, but also in most peripheral tissues. Here, we show that the...